Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 286

Similar articles for PubMed (Select 17556852)

1.

Olanzapine increases grey and white matter volumes in the caudate nucleus of patients with schizophrenia.

Okugawa G, Nobuhara K, Takase K, Saito Y, Yoshimura M, Kinoshita T.

Neuropsychobiology. 2007;55(1):43-6. Epub 2007 Jun 8.

2.

Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment.

McClure RK, Carew K, Greeter S, Maushauer E, Steen G, Weinberger DR.

Schizophr Res. 2008 Jan;98(1-3):29-39. Epub 2007 Oct 31.

PMID:
17976957
3.

Altered white matter/gray matter proportions in the striatum of patients with schizophrenia: a volumetric MRI study.

Tamagaki C, Sedvall GC, Jönsson EG, Okugawa G, Hall H, Pauli S, Agartz I.

Am J Psychiatry. 2005 Dec;162(12):2315-21.

PMID:
16330596
4.

Reduced white matter volume of the caudate nucleus in patients with schizophrenia.

Takase K, Tamagaki C, Okugawa G, Nobuhara K, Minami T, Sugimoto T, Sawada S, Kinoshita T.

Neuropsychobiology. 2004;50(4):296-300.

PMID:
15539860
5.

Antipsychotic drug effects on brain morphology in first-episode psychosis.

Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M; HGDH Study Group.

Arch Gen Psychiatry. 2005 Apr;62(4):361-70.

PMID:
15809403
6.

Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia.

Lang DJ, Kopala LC, Vandorpe RA, Rui Q, Smith GN, Goghari VM, Lapointe JS, Honer WG.

Am J Psychiatry. 2004 Oct;161(10):1829-36.

PMID:
15465980
7.

Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment.

Chua SE, Deng Y, Chen EY, Law CW, Chiu CP, Cheung C, Wong JC, Lienenkaëmper N, Cheung V, Suckling J, McAlonan GM.

Psychol Med. 2009 May;39(5):793-800. doi: 10.1017/S0033291708004212. Epub 2008 Aug 20.

PMID:
18713487
8.

Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.

McClure RK, Phillips I, Jazayerli R, Barnett A, Coppola R, Weinberger DR.

Psychiatry Res. 2006 Dec 1;148(2-3):121-32. Epub 2006 Nov 9.

PMID:
17097276
9.

Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs.

Chakos MH, Lieberman JA, Bilder RM, Borenstein M, Lerner G, Bogerts B, Wu H, Kinon B, Ashtari M.

Am J Psychiatry. 1994 Oct;151(10):1430-6.

PMID:
7916539
10.

Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug.

Glenthoj A, Glenthoj BY, Mackeprang T, Pagsberg AK, Hemmingsen RP, Jernigan TL, Baaré WF.

Psychiatry Res. 2007 Apr 15;154(3):199-208. Epub 2007 Mar 13.

PMID:
17360162
11.

Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia.

Chua SE, Cheung C, Cheung V, Tsang JT, Chen EY, Wong JC, Cheung JP, Yip L, Tai KS, Suckling J, McAlonan GM.

Schizophr Res. 2007 Jan;89(1-3):12-21. Epub 2006 Nov 13.

PMID:
17098398
12.
13.

Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia.

Ebdrup BH, Glenthøj B, Rasmussen H, Aggernaes B, Langkilde AR, Paulson OB, Lublin H, Skimminge A, Baaré W.

J Psychiatry Neurosci. 2010 Mar;35(2):95-104.

14.

Changes in caudate volume after exposure to atypical neuroleptics in patients with schizophrenia may be sex-dependent.

Heitmiller DR, Nopoulos PC, Andreasen NC.

Schizophr Res. 2004 Feb 1;66(2-3):137-42.

PMID:
15061245
15.

Brain volume changes in first-episode schizophrenia: a 1-year follow-up study.

Cahn W, Hulshoff Pol HE, Lems EB, van Haren NE, Schnack HG, van der Linden JA, Schothorst PF, van Engeland H, Kahn RS.

Arch Gen Psychiatry. 2002 Nov;59(11):1002-10.

PMID:
12418933
16.

A manual and automated MRI study of anterior cingulate and orbito-frontal cortices, and caudate nucleus in obsessive-compulsive disorder: comparison with healthy controls and patients with schizophrenia.

Riffkin J, Yücel M, Maruff P, Wood SJ, Soulsby B, Olver J, Kyrios M, Velakoulis D, Pantelis C.

Psychiatry Res. 2005 Feb 28;138(2):99-113.

PMID:
15766634
17.

Increased grey matter densities in schizophrenia patients with negative symptoms after treatment with quetiapine: a voxel-based morphometry study.

Stip E, Mancini-Marïe A, Letourneau G, Fahim C, Mensour B, Crivello F, Dollfus S.

Int Clin Psychopharmacol. 2009 Jan;24(1):34-41. doi: 10.1097/YIC.0b013e32831daf6c.

PMID:
19077676
18.

Brain morphology in antipsychotic-naïve schizophrenia: a study of multiple brain structures.

Cahn W, Hulshoff Pol HE, Bongers M, Schnack HG, Mandl RC, Van Haren NE, Durston S, Koning H, Van Der Linden JA, Kahn RS.

Br J Psychiatry Suppl. 2002 Sep;43:s66-72.

PMID:
12271803
19.

Frontal and temporal volume size of grey and white matter in patients with schizophrenia: an MRI parcellation study.

Okugawa G, Tamagaki C, Agartz I.

Eur Arch Psychiatry Clin Neurosci. 2007 Aug;257(5):304-7. Epub 2007 Apr 26.

PMID:
17464546
20.

Regional striatal volume abnormalities in schizophrenia: effects of comorbidity for alcoholism, recency of alcoholic drinking, and antipsychotic medication type.

Deshmukh A, Rosenbloom MJ, De Rosa E, Sullivan EV, Pfefferbaum A.

Schizophr Res. 2005 Nov 15;79(2-3):189-200. Epub 2005 Jun 15.

PMID:
15963693
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk